Restrictive versus standard hyperhydration during high-dose cyclophosphamide for hematopoietic stem cell transplantation: a retrospective cohort study
Supportive Care in Cancer · 2026-03 · 34 (3)
DOI: 10.1007/s00520-026-10465-9 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Supportive Care in Cancer, online erschienen am 23.02.2026. Verfasst von R J Boosman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands. r.j.boosman@amsterdamumc.nl. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Cyclophosphamide, Cystitis, Hemorrhagic, Water-Electrolyte Imbalance. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Cyclophosphamide is a commonly used chemotherapeutic agent in hematopoietic stem cell transplantation (HSCT), but its use can lead to adverse effects such as hemorrhagic cystitis (HC) and electrolyte disturbances, including hyponatremia. While standard hydration protocols are used to mitigate these risks, the optimal regimen remains unclear. This study explores the impact of a restrictive hydration regimen on HC incidence and electrolyte imbalances in patients undergoing high-dose cyclophosphamide treatment as part of HSCT conditioning.
Methods
A retrospective cohort study was conducted at Amsterdam UMC, including patients who received high-dose cyclophosphamide as part of HSCT between 2016 and 2024. Patients were grouped based on hydration protocols: an original regimen (5 L of NaCl 0.45%/dextrose 2.5% per day) and a new restrictive regimen (1.5 L/m 2 /day of 0.65% NaCl). The primary endpoint was the incidence of HC, while secondary endpoints included sodium and potassium changes, fluid overload (measured by furosemide use), and clinical outcomes.
Results
HC occurred in 10/386 (2.6%) patients in the original protocol and 1/69 (1.4%) in the restrictive protocol (odds ratio [95% confidence interval]: 0.55 [0.03–2.96], p = 0.57). Clinically relevant hyponatremia was less common with the restrictive regimen (1.4%) than with the original protocol (4.4%), though the difference was not significant ( p = 0.27). On the other hand, patients receiving the restrictive regimen showed more clinically relevant hypokalemia (8.7% vs 5.9%, p = 0.28). Fluid overload, as indicated by furosemide use, was lower in the restrictive group albeit not statistically significant.
Conclusion
In this retrospective single-center cohort, we did not observe a higher incidence of HC or electrolyte imbalances with a restrictive hydration regimen compared to the original regimen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands. r.j.boosman@amsterdamumc.nl.
- Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands.
- Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Leuvenlaan 4, 3584 CE, Utrecht, the Netherlands.
- Department of Hematology, Amsterdam UMC, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands.
- Department of Blood Cell Research, Sanquin Research and Landsteiner Laboratory, Amsterdam, the Netherlands.
Zitieren
APA
Boosman, R. J., Chan, R. M., Nur, E., Huls, H. J., Crul, M., & Heerma van Voss, M. R. (2026). Restrictive versus standard hyperhydration during high-dose cyclophosphamide for hematopoietic stem cell transplantation: a retrospective cohort study. Supportive Care in Cancer, 34(3). https://doi.org/10.1007/s00520-026-10465-9
Vancouver
Boosman RJ, Chan RM, Nur E, Huls HJ, Crul M, Heerma van Voss MR. Restrictive versus standard hyperhydration during high-dose cyclophosphamide for hematopoietic stem cell transplantation: a retrospective cohort study. Supportive Care in Cancer. 2026;34(3). doi:10.1007/s00520-026-10465-9
BibTeX
@article{Boosman2026,
author = {Boosman, R J and Chan, R M and Nur, E and Huls, H J and Crul, M and Heerma van Voss, M R},
title = {Restrictive versus standard hyperhydration during high-dose cyclophosphamide for hematopoietic stem cell transplantation: a retrospective cohort study},
journal = {Supportive Care in Cancer},
year = {2026},
volume = {34},
number = {3},
doi = {10.1007/s00520-026-10465-9}
}
EUVIMED